Premium
New effective treatment options reinforce disease awareness: the case of transthyretin cardiac amyloidosis
Author(s) -
Perlini Stefano,
Mussinelli Roberta,
Salinaro Francesco
Publication year - 2021
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1002/ejhf.2111
Subject(s) - medicine , transthyretin , cardiac amyloidosis , disease , amyloidosis , heart failure , intensive care medicine , cardiomyopathy , restrictive cardiomyopathy , clinical trial , amyloid disease , heart failure with preserved ejection fraction , ejection fraction , cardiology , amyloid fibril , amyloid β
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom